Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Texas Health arlington Memorial Hospital located at 800 W Randol Mill Rd, Arlington, TX, 76012 & includes data from NPIs 1174533343, 1366859597
Dexur analyzed Q1 2017 (January to March 2017) Medicare claims data to benchmark 30 Day readmissions outcomes for Texas Health arlington Memorial Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 994 | 949 | ||||||||||
| Surgical | 183 | 178 | ||||||||||
| Non Surgical | 811 | 771 | ||||||||||
| Pulmonology | 167 | 156 | ||||||||||
| General Medicine | 150 | 136 | ||||||||||
| Gastroenterology & Endocrinology | 134 | 133 | ||||||||||
| Cardiovascular | 123 | 115 | ||||||||||
| Urology | 123 | 122 | ||||||||||
| Neurology | 69 | 66 | ||||||||||
| General Surgery | 67 | 64 | ||||||||||
| Orthopedics | 63 | 63 | ||||||||||
| Psychiatry & Mental Disorders | 36 | 35 | ||||||||||
| Oncology & Hematology | 27 | 26 | ||||||||||
| Spine | 19 | 19 |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Diabetes |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Vascular Procedures |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |